Research Activity

• – Factors that affect the cutaneous synthesis of vitamin D.
  Boston University Medical Center.
• – Evaluation of extra-renal production of 1,25 (OH)2D at the systemic and cellular level using tritiated 25 (OH)D [3H 25(OH)D] in nephrectomized mice
  Boston University Medical Center
• – Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17 beta-estradiol in postmenopausal women.
  Boston University Medical Center
• – A twelve-week, multi-center, double-blind, randomized, Placebo- controlled study of oral alendronate sodium (70 mg Once a week in patients with osteoporosis
  Boston University Medical Center
• – Evaluation of the effects of ultraviolet irradiation on  Vitamin D, Calcium Metabolism and Gene Expression
  Boston University Medical Center
• – Comparison of the effects of daily oral estradiol-3β-glucoside with daily oral micronized 17-β-estradiol (Estrace)
  Boston University Medical Center
• – The effect of single dose, timed phosphate administration on biochemical markers of the bone, serum PTH and phosphate in women with osteoporosis
  Boston University Medical Center
• – Prevalence and risk factors for osteoporosis in HIV-infected patients entering care and progression of disease associated with different combinations of antiretroviral therapy compared to those not on HIV therapy
  Boston University Medical Center
• – Evaluation of the potential benefit of alendronate (Fosamax) or pamidronate therapy in preventing bone loss, hypercalcemia,  hypercalciuria, and heterotopic ossification in patients with quadriplegia
  Boston University Medical Center
• – Evaluation of the safety and efficacy of luflonamide (Arava) for the treatment of psoriatic arthritis and skin lesions
  Boston University Medical Center
• – Evaluating the therapeutic efficacy and safety of the combination of Parathyroid Hormone (1-34) and calcipotriene (Dovonex) for treating Psoriasis
  Boston University Medical Center
• – Evaluation of the safety and efficacy of topical 19-nor-1,25- dihydroxyvitamin D3 for treating psoriasis
  Boston University Medical Center
• – Evaluation of the therapeutic efficacy and safety of topically administered Parathyroid Hormone Related Peptide analog Parathyroid Hormone (1-34) for the treatment of psoriasis
  Boston University Medical Center
• – Effects of low dose ultraviolet radiation on endogenous Vitamin D synthesis and metabolism in normal volunteer
  Boston University Medical Center
• – Evaluation of the safety and efficacy of topical 19-nor-1,2 D2 for treating Psoriasis
  Boston University Medical Center
• – Treatment of psoriasis with orally administered calcitriol (1,25-dihydroxyvitamin D3)
  Boston University Medical Center